{"version":"1.0","provider_name":"Alliance for Immunology Innovations (AII)","provider_url":"https:\/\/eutranslationalmedicine.org\/aii","author_name":"admin","author_url":"https:\/\/eutranslationalmedicine.org\/aii\/author\/admin\/","title":"Inflammatory Diseases - Alliance for Immunology Innovations (AII)","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"hKmbykREus\"><a href=\"https:\/\/eutranslationalmedicine.org\/aii\/inflammatory-diseases-2\/\">Inflammatory Diseases<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/eutranslationalmedicine.org\/aii\/inflammatory-diseases-2\/embed\/#?secret=hKmbykREus\" width=\"600\" height=\"338\" title=\"&#8220;Inflammatory Diseases&#8221; &#8212; Alliance for Immunology Innovations (AII)\" data-secret=\"hKmbykREus\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/eutranslationalmedicine.org\/aii\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Chronic inflammatory diseases, including conditions such as inflammatory bowel disease (IBD), psoriasis, ankylosing spondylitis, and systemic vasculitis, affect millions and often overlap with autoimmune and metabolic disorders. Biopharma companies are developing advanced biologics, small molecules, and precision diagnostics to modulate inflammation, block key pathways, and offer lasting symptom relief with fewer side effects. Key Focus [&hellip;]"}